Milvus Technology

Milvus Technology operates as a wholly-owned subsidiary of Yuanhua Technology, established in 2019 to focus exclusively on wireless capsule endoscopy systems for gastrointestinal examination, diagnosis, and treatment.

Company Overview

Founded as part of Yuanhua Technology’s strategic expansion into multi-specialty medical robotics, Milvus Technology (妙微视科技) concentrates on developing advanced capsule endoscopy platforms. The parent company, Yuanhua Technology, was established in 2018 in Shenzhen under the leadership of Academician Meng Qinghu, a chair professor at Southern University of Science and Technology who received the prestigious IROS Harashima Award for Innovative Technologies in 2025.

Yuanhua Technology created two wholly-owned subsidiaries in 2019: Gusheng Yuanhua Robot (骨圣元化) for orthopedic surgical robots and Milvus Technology for digestive tract endoscopy systems. This dual-track approach allows each entity to focus on its respective clinical domain while sharing core robotics and AI capabilities developed by the parent company.

Core Products

Milvus Wireless Capsule Endoscopy System

The flagship product line includes two distinct models designed for full gastrointestinal tract examination:

Passive Capsule Endoscopy System

• Propelled by natural gastrointestinal peristalsis
• Paired with wearable data receiving device
• Enables examination at any time and location
• Suitable for routine small bowel screening

Active Capsule Endoscopy System

• Based on robotic control and sensing technologies
• Bi-directional interactive control capability
• High frame-rate image capture with real-time transmission
• AI-assisted diagnostic software for automatic image analysis
• Enables full examination of the entire GI tract

Technology & Innovation

The active capsule endoscopy system represents Milvus Technology’s core innovation, combining multiple advanced technologies:

• Robotic Control: Precise capsule navigation throughout the digestive tract
• Advanced Optics: High-definition imaging with optimized frame rates
• Real-time Transmission: Wireless image transfer to external monitoring systems
• AI Diagnostics: Automated analysis software for detecting GI abnormalities

This technology platform addresses limitations of traditional passive capsule endoscopy by providing physicians with interactive control over the examination process, potentially improving diagnostic accuracy for gastric and colonic regions where passive transit may be suboptimal.

Market Position

Capsule endoscopy has emerged as an important modality for non-invasive GI examination, particularly for small bowel visualization where traditional endoscopy has limited reach. The Chinese market for such devices continues to expand as healthcare systems emphasize early detection of GI pathologies.

Milvus Technology competes in a segment that includes established players such as Ankon Technologies (安翰科技) and Jinshan Science & Technology (金山科技), both of which have commercialized magnetic-controlled capsule endoscopy systems in China.

Parent Company Resources

As a Yuanhua Technology subsidiary, Milvus Technology benefits from:

• Access to the parent company’s robotics R&D infrastructure
• Shared AI and sensing technology platforms
• Combined funding resources (Yuanhua Technology has raised over $30 million through Series B)
• Cross-pollination with orthopedic robotics expertise

Frequently Asked Questions

What is the relationship between Milvus Technology and Yuanhua Technology?

Milvus Technology is a wholly-owned subsidiary of Yuanhua Technology, established in 2019. While Yuanhua Technology focuses on orthopedic surgical robots through another subsidiary (Gusheng Yuanhua), Milvus Technology specializes in gastrointestinal diagnostic devices.

What types of capsule endoscopy systems does Milvus Technology offer?

The company offers two models: a passive system that relies on natural GI peristalsis, and an active system with robotic control capabilities that allows physicians to navigate the capsule through the digestive tract.

Has Milvus Technology received NMPA approval for its products?

Specific NMPA approval status for Milvus capsule endoscopy products has not been confirmed through public sources. The products appear to be in various stages of development and clinical validation.